搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
10类诺贝尔奖级创新疗法公布!
▎药明康德内容团队编辑2024年诺贝尔奖进入倒计时。作为科学界的最高荣誉,诺贝尔奖已经走过了一个多世纪。在这100多年里,科学家们取得了一系列突破性发现和研究进展,为科学的发展和人类社会的进步做出了开拓性贡献。在这其中,有一些发现与人类的健康和生命息 ...
6 小时
Shattuck Labs (STTK) was downgraded to a Hold Rating at H.C. Wainwright
Shattuck Labs (STTK – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Joseph Pantginis today. The ...
News Medical
8 小时
The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance
A new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, "Linking FOXM1 and PD-L1 to CDK4/6 ...
snmjournals.org
11 小时
Nuclear Imaging of Bispecific Antibodies on the Rise
Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...
Armed robbery in Revesby
12 小时
FOXM1, PD-L1 Linked to CDK4/6-MEK Resistance in Nerve Tumors
We suggest that future therapeutic strategies targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 represent ...
Armed robbery in Revesby
13 小时
Woman Missing From Westmead Located 2 October
Good news!A 30-year-old woman missing from the Westmead area has been located safe.Police would like to thank the public and media for their ...
13 小时
多款创「首个」记录!九月,9 款抗肿瘤新药在国内申报上市
9 月已经结束。根据 Insight 数据库,有 9 款为抗肿瘤新药在九月向 CDE 递交了上市申请,包括 4 个新药的首次 NDA 和 5 款新药的新适应症/新剂型 NDA,适应症涉及鼻咽癌、大 B ...
14 小时
Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
WARMINSTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...
中時新聞網
15 小时
长圣9月营收再创新高 估第四季业绩更好
长圣(6712)受惠于CDMO服务与全台19家医疗机构合作,自结9 月营收以9,002万元再创新高,连续9个月长红,累计前九月营收达5.89 亿元,年增率高达17.16%,再次刷新同期新高纪录,预期第四季营收将更好。总经理黄文良表 ...
16 小时
Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market ...
Immune checkpoint inhibitors industry is projected to witness a CAGR of 16.7% during the period 2024-2032. This growth can be ...
21 小时
Buy Rating Affirmed for Merus on Strong Clinical Trial Progress and Competitive Positioning
Analyst Charles Zhu of LifeSci Capital maintained a Buy rating on Merus (MRUS – Research Report), retaining the price target of $100.00.
腾讯网
22 小时
FDA或收窄PD-1适应证 中国会跟进吗
经济观察网 记者 瞿依贤 北京时间9月27日,美国食品药品监督管理局(FDA)肿瘤药物专家咨询委员会(ODAC)的一场会议结束,历时9个小时。这场会议的讨论结果可能让国内外的PD-1类药物市场大变。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈